Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Clinical trial NCT02164864 · COMPLETED

Trial details

NCT number

NCT02164864

Sponsor

Boehringer Ingelheim

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2014-07-22

Primary completion

2017-06-05

Enrollment

2725

View on ClinicalTrials.gov